Lucid Diagnostics (LUCD) Cost of Revenue (2020 - 2026)

Lucid Diagnostics' Cost of Revenue history runs 7 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• Quarterly Cost of Revenue rose 4.77% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (down 3.56% YoY) and the FY2025 annual result came in at $6.7 million, down 6.04% from the prior year.
• Cost of Revenue was $1.6 million for Q1 2026 at Lucid Diagnostics, down from $1.9 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.1 million in Q4 2024 and bottomed at $369000.0 in Q1 2022.
• A 5-year average of $1.6 million and a median of $1.6 million in 2022 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue surged 442.17% — and 2025, when it retreated 13.29%.
• Lucid Diagnostics' Cost of Revenue stood at $1.6 million in 2022, then dropped by 9.95% to $1.5 million in 2023, then jumped by 47.22% to $2.1 million in 2024, then fell by 13.29% to $1.9 million in 2025, then declined by 12.63% to $1.6 million in 2026.
• Business Quant data shows LUCD's Cost of Revenue at $1.6 million in Q1 2026, $1.9 million in Q4 2025, and $1.7 million in Q3 2025.